
Univest Blogs

Astec Lifesciences Q2 Results FY27: Net Loss Widens to Rs 37.40 Cr, Revenue Rs 72.02 Cr
26 October 2026
13 min read

REC Q2 Results FY27: PAT Falls 21.23% to Rs 3,477.73 Cr, Revenue Rs 15,000.40 Cr
26 October 2026
12 min read


4 Smallcap Government Capex Stocks to Watch for Future Multibagger Potential: Kalpataru Projects, Engineers India, RITES and Power Mech
26 October 2026
15 min read

4 Smallcap Export Stocks to Watch for Future Multibagger Potential: Tata Elxsi, Happy Forgings, CCL Products and Zensar
26 October 2026
15 min read

4 Smallcap Rural Demand Stocks to Watch for Future Multibagger Potential: Force Motors, Sumitomo Chemical, Paradeep Phosphates and Gokul Agro
26 October 2026
16 min read

4 Smallcap China Plus One Stocks to Watch for Future Multibagger Potential: Himadri, Sundram Fasteners, Garware Hi-Tech Films and Avalon Technologies
26 October 2026
16 min read


4 Smallcap Festive Season Stocks to Watch for Future Multibagger Potential: Jubilant FoodWorks, Metro Brands, Bikaji Foods and PN Gadgil Jewellers
26 October 2026
16 min read

4 Midcap Rising Promoter Holding Stocks to Watch for Future Multibagger Potential: Aditya Birla Capital, Dabur, Kalyan Jewellers and Astral
26 October 2026
16 min read

4 Midcap Rs 1,000 Crore Profit Stocks to Watch for Future Multibagger Potential: Lupin, Federal Bank, Oberoi Realty and NMDC
26 October 2026
16 min read

4 Midcap Government Capex Stocks to Watch for Future Multibagger Potential: Mazagon Dock, Apar Industries, Oil India and Astral
26 October 2026
16 min read

RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times

FAQs
Yes, Univest owns SEBI-registered entities as its subsidiaries such as Uniresearch India Pvt. Ltd. SEBI-registered RA (INH00013776) and Univest Stock Broking Pvt. Ltd., a SEBI-registered stock broker (INZ000317437). Check the further details of registration on the official website.
Univest offers trade ideas for stocks, futures, options, and commodities with the help of SEBI-registered research analysts. Univest performs AI-powered research to provide trade ideas with curated strategies and buy/sell/hold ratings for over 2,000 stocks. Investors may access the subscription plan to check their trade ideas for the duration of 1-month, 3-months, or 12-months.
Free trial of Univest is now available for new users who sign up for the first time. After sign up, user can avail 3 free trade ideas from highly skilled SEBI-registered research analysts. Visit the website now and sign up to get free trade ideas on Univest.
Univest maintains the confidentiality of user data by adhering to severe security measures and regulatory requirements. Sensitive details are encrypted with cutting-edge technology to avoid unauthorised access. The app abides by SEBI guidelines and data protection regulations in India, maintaining user confidence and transparency. Univest never shares personal or financial information with third parties without permission. Regular audits, secure servers, and AI-powered monitoring further enhance protection. Through these initiatives, Univest ensures that the investment process of each user is secure, confidential, and not subject to abuse of their personal details.
Univest stands out as a one-stop shop for investors looking for a research-based brokerage platform. It provides:
- Unbiased Stock Recommendations-Backed by SEBI-Reg. Experts.
- Integration of Research and Execution Via Linked Demat Account.
- Affordable Plans Starting Around ₹5 Per Day.
- AI-Integrated Platform With Seamless Human Intervention.
- Offers Real-Time Entry & Exit Signals During Market Hours.
The approach of Univest to research stock recommendations includes experienced SEBI-registered analysts with 75+ years of combined experience in leading the research procedure. Moreover, AI is being used to help screen and generate stock ideas, which are analysed and validated by seasoned analysts. The advisory part of Univest remains separate from the brokerage arm to eliminate the chances of conflicts of interest.
